*اليوم إن شاء الله بداية الكورس الساعة 7 مساء بتوقيت السودان*
🔷 *فقط ب 7 ألف للدفعة دي بدلا عن 10 ألف*
🔷طريقة الدراسة: الكورس في شكل تسجيلات صوتية مشروح من مراجع
🔷للتسجيل والاستفسار: 0110753218
*Contents of immunohematology Course*
🟣ABO blood grouping system 🟣Rh blood grouping system 🟣Minor blood grouping system 🟣Pre transfusion testing 🟣Compatibility testing 🟣Donor screening 🟣Blood components and their administration 🟣Apheresis 🟣 Hemolytic transfusion reaction 🟣Hemolytic disease of fetus and newborn
*اليوم إن شاء الله بداية الكورس الساعة 7 مساء بتوقيت السودان*
🔷 *فقط ب 7 ألف للدفعة دي بدلا عن 10 ألف*
🔷طريقة الدراسة: الكورس في شكل تسجيلات صوتية مشروح من مراجع
🔷للتسجيل والاستفسار: 0110753218
*Contents of immunohematology Course*
🟣ABO blood grouping system 🟣Rh blood grouping system 🟣Minor blood grouping system 🟣Pre transfusion testing 🟣Compatibility testing 🟣Donor screening 🟣Blood components and their administration 🟣Apheresis 🟣 Hemolytic transfusion reaction 🟣Hemolytic disease of fetus and newborn
BY HEMATOLOGY WORLD🔬
Warning: Undefined variable $i in /var/www/tg-me/post.php on line 283
At a time when the Indian stock market is peaking and has rallied immensely compared to global markets, there are companies that have not performed in the last 10 years. These are definitely a minor portion of the market considering there are hundreds of stocks that have turned multibagger since 2020. What went wrong with these stocks? Reasons vary from corporate governance, sectoral weakness, company specific and so on. But the more important question is, are these stocks worth buying?
To pay the bills, Mr. Durov is issuing investors $1 billion to $1.5 billion of company debt, with the promise of discounted equity if the company eventually goes public, the people briefed on the plans said. He has also announced plans to start selling ads in public Telegram channels as soon as later this year, as well as offering other premium services for businesses and users.
